LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Testosterone Linked to Higher Rate of Colon Cancer in Males

By LabMedica International staff writers
Posted on 22 Dec 2014
Image: Micrograph of lymph node with colorectal carcinoma (Photo courtesy of Wikimedia Commons).
Image: Micrograph of lymph node with colorectal carcinoma (Photo courtesy of Wikimedia Commons).
Results of experiments carried out with two established animal colon cancer models indicated that the male hormone testosterone was responsible for males having a greater likelihood of developing the disease.

It has been recognized recently that men develop colonic adenomas and carcinomas at an earlier age and at a higher rate than women. This sex susceptibility also occurs in the ApcPirc/+ (Pirc) rat model of early colonic cancer, with male Pirc rats developing twice as many adenomas as females. The ApcMin/+ mouse also shows enhanced male susceptibility to cancer formation, but only in the colon.

Investigators at the University of Missouri (Columbia, USA) worked with these two rodent populations to determine whether the males' natural high levels of testosterone or the lack of female hormones was related to the increased development of colon cancer.

They reported in the November 3, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that removing testosterone from the rodents by castration caused colon cancer rates to decrease dramatically. Restoration of testosterone by dietary supplementation restored the tendency for cancer development. In contrast, removal of the ovaries, which eliminated female hormones, did not cause an increase in rate of cancer development. Dietary supplementation of female hormones also failed to have any effect.

“Previously, scientists believed that female hormones may have lent some sort of protection against tumor susceptibility,” said first author Dr. James Amos-Landgraf, assistant professor of veterinary pathobiology at the University of Missouri. “However, by showing that removing testosterone from rats leads to a drastic decrease in colon cancer susceptibility, it appears that male hormones may actually contribute to colon tumor growth rather than female hormones being protective. All women have some level of testosterone in their bodies naturally, but those levels typically are much lower than estrogen and other female hormones. Once women experience menopause and their female hormone levels decrease, their testosterone levels become relatively higher. This corresponds to the time when they begin to experience higher rates of colon cancer and could be a sign of a relationship between testosterone levels and colon tumor growth.”

Related Links:

University of Missouri


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more